These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 26450749)

  • 1. Outcomes in Advanced Head and Neck Cancer Treated with Up-front Neck Dissection prior to (Chemo)Radiotherapy.
    Elicin O; Albrecht T; Haynes AG; Bojaxhiu B; Nisa L; Caversaccio M; Dal Pra A; Schmücking M; Aebersold DM; Giger R
    Otolaryngol Head Neck Surg; 2016 Feb; 154(2):300-8. PubMed ID: 26450749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observation versus neck dissection for positron-emission tomography-negative lymphadenopathy after chemoradiotherapy.
    Khodayari B; Daly ME; Bobinski M; Farwell DG; Shelton DK; Chen AM
    Laryngoscope; 2014 Apr; 124(4):902-6. PubMed ID: 24115118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upfront vs. no upfront neck dissection in primary head and neck cancer radio(chemo)therapy: Tumor control and late toxicity.
    Nevens D; Duprez F; Bonte K; Deron P; Huvenne W; Laenen A; De Neve W; Nuyts S
    Radiother Oncol; 2017 Aug; 124(2):220-224. PubMed ID: 28756006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-front neck dissection followed by definitive (chemo)-radiotherapy in head and neck squamous cell carcinoma: Rationale, complications, toxicity rates, and oncological outcomes - A systematic review.
    Elicin O; Nisa L; Dal Pra A; Bojaxhiu B; Caversaccio M; Schmücking M; Aebersold DM; Giger R
    Radiother Oncol; 2016 May; 119(2):185-93. PubMed ID: 26996775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In patients with metastatic cutaneous head and neck squamous cell carcinoma to cervical lymph nodes, the extent of neck dissection does not influence outcome.
    Wang JT; Palme CE; Wang AY; Morgan GJ; Gebski V; Veness MJ
    J Laryngol Otol; 2013 Jan; 127 Suppl 1():S2-7. PubMed ID: 23046820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion of extracapsular spread in the pTNM classification system: a proposal for patients with head and neck carcinoma.
    de Juan J; García J; López M; Orús C; Esteller E; Quer M; León X
    JAMA Otolaryngol Head Neck Surg; 2013 May; 139(5):483-8. PubMed ID: 23681031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
    Balk M; Rupp R; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Traxdorf M; Eckstein M; Speer S; Semrau S; Fietkau R; Iro H; Hecht M; Gostian AO
    BMC Cancer; 2021 Nov; 21(1):1236. PubMed ID: 34794411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elective neck dissection for second primary after previous definitive radiotherapy.
    Falchook AD; Dagan R; Morris CG; Mendenhall WM
    Am J Otolaryngol; 2012; 33(2):199-204. PubMed ID: 21658804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neck dissection for unknown cancer of the head and neck in the era of chemoradiation.
    Amsbaugh MJ; Yusuf M; Gaskins J; Silverman C; Potts K; Bumpous J; Redman R; Perez C; Dunlap N
    Am J Otolaryngol; 2017; 38(5):588-592. PubMed ID: 28633765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of salvage neck dissections in head and neck cancer in relation to initial treatment, extent of surgery and patient factors.
    van den Bovenkamp K; Noordhuis MG; Oosting SF; van der Laan BFAM; Roodenburg JL; Bijl HP; Halmos GB; Plaat BEC
    Clin Otolaryngol; 2017 Jun; 42(3):693-700. PubMed ID: 28032952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer.
    Schilling C; Stoeckli SJ; Haerle SK; Broglie MA; Huber GF; Sorensen JA; Bakholdt V; Krogdahl A; von Buchwald C; Bilde A; Sebbesen LR; Odell E; Gurney B; O'Doherty M; de Bree R; Bloemena E; Flach GB; Villarreal PM; Fresno Forcelledo MF; Junquera Gutiérrez LM; Amézaga JA; Barbier L; Santamaría-Zuazua J; Moreira A; Jacome M; Vigili MG; Rahimi S; Tartaglione G; Lawson G; Nollevaux MC; Grandi C; Donner D; Bragantini E; Dequanter D; Lothaire P; Poli T; Silini EM; Sesenna E; Dolivet G; Mastronicola R; Leroux A; Sassoon I; Sloan P; McGurk M
    Eur J Cancer; 2015 Dec; 51(18):2777-84. PubMed ID: 26597442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options.
    Strojan P; Ferlito A; Langendijk JA; Corry J; Woolgar JA; Rinaldo A; Silver CE; Paleri V; Fagan JJ; Pellitteri PK; Haigentz M; Suárez C; Robbins KT; Rodrigo JP; Olsen KD; Hinni ML; Werner JA; Mondin V; Kowalski LP; Devaney KO; de Bree R; Takes RP; Wolf GT; Shaha AR; Genden EM; Barnes L
    Head Neck; 2013 Feb; 35(2):286-93. PubMed ID: 22034062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-effectiveness analysis of positron emission tomography-computed tomography surveillance versus up-front neck dissection for management of the neck for N2 disease after chemoradiotherapy.
    Rabalais A; Walvekar RR; Johnson JT; Smith KJ
    Laryngoscope; 2012 Feb; 122(2):311-4. PubMed ID: 22252963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Planned neck dissection before combined chemoradiation in organ preservation protocol for N2-N3 of supraglottic or hypopharyngeal carcinoma.
    Liu XK; Li Q; Zhang Q; Su Y; Shi YX; Li H; Zeng ZY; Guo ZM
    ORL J Otorhinolaryngol Relat Spec; 2012; 74(2):64-9. PubMed ID: 22327028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardized uptake value and resection margin involvement predict outcomes in pN0 head and neck cancer.
    Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim MS
    Otolaryngol Head Neck Surg; 2013 Nov; 149(5):721-6. PubMed ID: 23921497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection?
    Cho AH; Shah S; Ampil F; Bhartur S; Nathan CO
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1112-8. PubMed ID: 19917924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of neck dissection before definitive radiation therapy for locoregionally advanced squamous cell carcinoma of the head and neck].
    Modesto A; Sarini J; Benlyazid A; Ouali M; Laprie A; Graff P; Vergez S; Uro-Coste E; Fauquet I; Delord JP; Rives M
    Cancer Radiother; 2016 Feb; 20(1):18-23. PubMed ID: 26749214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.